Peter Anastasiou is an accomplished executive and CEO, with more than 30 years of experience managing diverse, global organizations of up to 1,200 people with net revenues of $1.5 billion. As CEO of Capsida Biotherapeutics, Peter is helping build an industry-leading gene therapy platform company creating a new class of targeted, non-invasive gene therapies for patients with debilitating and life-threatening disorders.
But most people don’t know that Peter had a cancer at the age of three which profoundly affected his career choice. His Greek heritage also taught him a lot about overcoming the travails of life and the importance of family.
Named by Time as one of the 50 most influential people in healthcare, Sean Harper, MD, is a luminary in the biopharma industry, having spent his career creating life-changing medicines for millions of patients. Before his current role as founding managing director of Los Angeles-based VC powerhouse Westlake Village BioPartners, Sean headed R&D at Amgen, investing more than $3.5 billion annually in new medicines.
But there is another side to Sean. His passion is fly fishing and in today’s episode, he shares his obsession with reeling in that perfect catch.
Veteran biotech executive and neuroscientist, Nancy Stagliano, PhD, has always been fascinated by how the brain works, which is a good thing considering she is CEO of Neuron23, a Bay Area biotechnology company developing personalized medicines for genetic disorders. During her career, Nancy has been CEO of three successful biotech companies and is passionate about finding new therapies that make a difference for patients.
But most people don’t know that Nancy also has another passion: horses. And they have taught her some surprising lessons about the human condition.